TGTX icon

TG Therapeutics

235 hedge funds and large institutions have $762M invested in TG Therapeutics in 2023 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 51 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

4% less funds holding

Funds holding: 244235 (-9)

13% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 54

65% less capital invested

Capital invested by funds: $2.19B → $762M (-$1.43B)

Holders
235
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.3M
Puts
$24M
Net Calls
Net Calls Change

Top Sellers

1 -$230M
2 -$43.1M
3 -$40.4M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$38.4M
5
Man Group
Man Group
United Kingdom
-$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275